CAMBRIDGE, Mass.--(BUSINESS WIRE)--Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that it will participate in the Leerink Swann Roundtable Conference on Emerging Products and Applications of Life Science Tools on Thursday, August 9. Steve Lombardi, Executive Vice President and Chief Operating Officer will participate in a panel discussion on “Emerging Products and Applications in DNA Sequencing” at 8:30 a.m., and will be interviewed by a Leerink Swann financial analyst at 9:50 a.m..
